ORKA Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. (ORKA) is expected to report earnings on February 8, 2027, after the market close. The consensus earnings estimate is a loss of $0.78 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.6% since its last earnings release on November 9, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Oruka Therapeutics, Inc.
Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases.
Sector
Healthcare
Industry
Biotechnology
Held By 1 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.